Yang, B., Lin, Y., Huang, Y., Shen, Y
Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)
it cant specifically target belly fat, but it helps decrease overall body fat percentage
Understanding your genetic profile helps explain why your sugar cravings might change differently than someone else's
Also eine Win-Win-Situation
Know Local Regulations If traveling internationally, research the medication and medical supply regulations of your destination country to avoid issues at customs